CD4 and immunodeficiency disease: The proportion of patients with positive test results among those with severe immunodeficiency (CD4 count <100 cells/μl) was higher with IGRAs as compared to the TST (26% vs. 13%, p = 0.12) but the differences were not statistically significant.